DXT — Dexterra Income Statement

0.000.00%

Last trade - 00:00

Consumer CyclicalsConservativeMid CapSuper Stock

Annual income statement for Dexterra, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	733	972	928	1,003	1,041
Cost of Revenue
Gross Profit	102	103	141	160	187
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	697	961	869	936	977
Operating Profit	36	10.1	59	67.1	64.4
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	33.3	3.22	47.5	53.6	54.7
Provision for Income Taxes
Net Income After Taxes	24.6	3.71	35.8	37.5	40.8
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	24.4	3.43	26.6	19.9	40.5
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	24.4	3.43	26.6	19.9	40.5
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.286	0.199	0.655	0.58	0.672
Dividends per Share